SCHEMBL17023154

SCHEMBL17023154

COc1cc(OC)c(Cl)c(-c2ccc(OC(=O)Nc3ccc(N4CCN(C)CC4)cc3)c3nccnc23)c1Cl

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 14/20 0.65
NPC1 O15118 1/20 0.49
POLB P06746 1/20 0.49
RAB9A P51151 1/20 0.49
HTR1A P08908 1/20 0.49
HTR1D P28221 1/20 0.49
HTR1B P28222 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
HTR6 P50406 1/20 0.49
GAA P10253 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
FGFR1 P11362 2/20 0.46
KDR P35968 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023066 0.91 FGFR3 (0.78) FGFR3NPC1RAB9AMAPTFGFR1
SCHEMBL17023062 0.91 FGFR3 (0.66) FGFR3NPC1POLBRAB9AMAPT
SCHEMBL17023056 0.91 FGFR3 (0.79) FGFR3NPC1RAB9AFGFR1
SCHEMBL17023048 0.90 FGFR3 (0.64) FGFR3FGFR1
SCHEMBL1126459 0.88 FGFR3 (0.84) FGFR3NPC1RAB9AMAPTTSHR
SCHEMBL17023040 0.84 FGFR3 (0.55) FGFR3POLB
SCHEMBL17023138 0.83 FGFR3 (0.67) FGFR3
SCHEMBL17023181 0.82 FGFR3 (0.59) FGFR3POLBFGFR1KDR
SCHEMBL17023176 0.81 FGFR3 (0.80) FGFR3FGFR1KDR
SCHEMBL17023042 0.81 FGFR3 (0.61) FGFR3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed